ES8802154A1 - Procedimiento para la produccion de tiazoles., - Google Patents

Procedimiento para la produccion de tiazoles.,

Info

Publication number
ES8802154A1
ES8802154A1 ES556363A ES556363A ES8802154A1 ES 8802154 A1 ES8802154 A1 ES 8802154A1 ES 556363 A ES556363 A ES 556363A ES 556363 A ES556363 A ES 556363A ES 8802154 A1 ES8802154 A1 ES 8802154A1
Authority
ES
Spain
Prior art keywords
psychogeriatric
agents
anxioltic
antisepressant
antischiziphrenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES556363A
Other languages
English (en)
Other versions
ES556363A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES556363A0 publication Critical patent/ES556363A0/es
Publication of ES8802154A1 publication Critical patent/ES8802154A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

LOS TIADIZOLES (I), DONDE NO EXCLUSIVAMENTE R1 Y R2 SON ALQUILO C1-6 O FENILO, X-Y-N-CH2, CFCH, W ALQUILENO C2-6 Y R3, UN GRUPO TIPO (II) O (III); SE OBTIENEN ENTRE OTROS, POR REACCION DE UN COMPUESTO (IV) CON OTRO Q-W-R''3, CON Q UN GRUPO ELIMINABLE COMO HALOGENO O -O-SO2-R13, EN DISOLVENTE COMO LA DIMETILFORMAMIDA, EN PRESENCIA DE UN AGENTE LIGADOR DE ACIDO, COMO EL CARBONATO DE POTASIO, EN ATMOSFERA DE ARGON Y ENTRE C60 Y C50JC. TIENEN UNA ACTIVIDAD MEJORADORA DE LA INTERACCION SOCIAL Y REDUCTORA DEL CONFLICTO Y AFINIDAD POR LOS LUGARES DE LIGACION 5HT-1A, POR LO QUE SON APLICABLES , COMO ANXIOLITICOS, PSICOGERIATRICOS, ANTIDEPRESIVOS Y ANTIESQUIZOFRENICOS.
ES556363A 1985-06-22 1986-06-20 Procedimiento para la produccion de tiazoles., Expired ES8802154A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3522353 1985-06-22
DE3522351 1985-06-22
DE3522354 1985-06-22
DE3605868 1986-02-24

Publications (2)

Publication Number Publication Date
ES556363A0 ES556363A0 (es) 1988-04-01
ES8802154A1 true ES8802154A1 (es) 1988-04-01

Family

ID=27433378

Family Applications (2)

Application Number Title Priority Date Filing Date
ES556363A Expired ES8802154A1 (es) 1985-06-22 1986-06-20 Procedimiento para la produccion de tiazoles.,
ES557723A Expired ES8802045A1 (es) 1985-06-22 1987-09-15 Procedimiento para la produccion de tiazoles

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES557723A Expired ES8802045A1 (es) 1985-06-22 1987-09-15 Procedimiento para la produccion de tiazoles

Country Status (17)

Country Link
US (2) US4737500A (es)
AU (1) AU5894086A (es)
BE (1) BE904945A (es)
CH (1) CH668426A5 (es)
DK (1) DK292986A (es)
ES (2) ES8802154A1 (es)
FI (1) FI862644A (es)
FR (1) FR2587342A1 (es)
GB (1) GB2177395B (es)
GR (1) GR861601B (es)
HU (1) HUT43600A (es)
IL (1) IL79178A0 (es)
IT (1) IT1203806B (es)
LU (1) LU86487A1 (es)
NL (1) NL8601494A (es)
PH (1) PH23389A (es)
SE (1) SE8602723L (es)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
HUT43600A (en) * 1985-06-22 1987-11-30 Sandoz Ag Process for production of new thiazole derivatives and medical compound containing those
MX173362B (es) * 1987-03-02 1994-02-23 Pfizer Compuestos de piperazinil heterociclicos y procedimiento para su preparacion
FR2612187B1 (fr) * 1987-03-12 1989-07-21 Sanofi Sa Derives du thiazole actifs sur le systeme cholinergique, leur procede de preparation et compositions pharmaceutiques en contenant
US4804751A (en) * 1987-06-30 1989-02-14 American Home Products Corporation Polycyclic hydrocarbon succinimides with psychotropic activity
EP0307141B1 (en) * 1987-09-10 1993-01-13 MERCK SHARP & DOHME LTD. Oxazoles and thiazoles for the treatment of senile dementia
US4883795A (en) * 1988-01-22 1989-11-28 Pfizer Inc. Piperazinyl-heterocyclic compounds
EP0350145A3 (en) * 1988-04-28 1990-07-04 Yamanouchi Pharmaceutical Co. Ltd. Pyridylthiazolidine carboxamide derivatives and their intermediates and production of both
US4935424A (en) * 1988-05-27 1990-06-19 Warner-Lambert Company 4 or 5-(substituted piperazinylalkyl)-2-aminothiazoles as antipsychotic agents
US4957916A (en) * 1988-08-05 1990-09-18 Janssen Pharmaceutica N.V. Antipsychotic 3-piperazinylbenzazole derivatives
US5015740A (en) * 1988-08-05 1991-05-14 Janssen Pharmaceutica N.V. Antipsychotic 3-piperazinylbenzazole derivatives
HUT61760A (en) * 1988-09-16 1993-03-01 Pfizer Process for producing bridged, bicyclic imides comprising 4-/4-(3-benzisothiazolyl)-1-piperazinyl/-butyl group and pharmaceutical compositions comprising such compounds
US4954503A (en) * 1989-09-11 1990-09-04 Hoechst-Roussel Pharmaceuticals, Inc. 3-(1-substituted-4-piperazinyl)-1H-indazoles
US5130315A (en) * 1991-01-10 1992-07-14 Raymond R. Wittekind 1-piperazinyl-2-butenes and -2-butynes
US5194436A (en) * 1991-01-10 1993-03-16 Hoechst-Roussel Pharmaceuticals Inc. 1-piperazinyl-2-butenes and -2-butynes
IT1251144B (it) * 1991-07-30 1995-05-04 Boehringer Ingelheim Italia Derivati del benzimidazolone
ES2236700T3 (es) * 1993-11-19 2005-07-16 Janssen Pharmaceutica N.V. 1,2-benzazoles microencapsulados.
US5889010A (en) * 1995-05-18 1999-03-30 Pfizer Inc. Benzimidazole derivatives having dopaminergic activity
DE19746612A1 (de) 1997-10-22 1999-04-29 Basf Ag 2-Substituierte 1,2-Benzisothiazol-Derivate, ihre Herstellung und Verwendung
US7183410B2 (en) * 2001-08-02 2007-02-27 Bidachem S.P.A. Stable polymorph of flibanserin
US20030060475A1 (en) * 2001-08-10 2003-03-27 Boehringer Ingelheim Pharma Kg Method of using flibanserin for neuroprotection
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
KR20070014184A (ko) * 2004-04-22 2007-01-31 베링거 인겔하임 인터내셔날 게엠베하 성기능 장애 치료용 신규 약제학적 조성물 ⅱ
US20050239798A1 (en) * 2004-04-22 2005-10-27 Boehringer Ingelheim Pharmaceuticals, Inc. Method for the treatment of premenstrual and other female sexual disorders
US20060025420A1 (en) * 2004-07-30 2006-02-02 Boehringer Ingelheimn International GmbH Pharmaceutical compositions for the treatment of female sexual disorders
JP2008511569A (ja) * 2004-09-03 2008-04-17 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 注意欠如活動過多障害の治療方法
JP2008531714A (ja) * 2005-03-04 2008-08-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 不安障害の治療用及び／又は予防用の医薬組成物
WO2006096439A2 (en) * 2005-03-04 2006-09-14 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
WO2006096435A1 (en) * 2005-03-04 2006-09-14 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of depression
WO2006119884A2 (en) * 2005-05-06 2006-11-16 Boehringer Ingelheim International Gmbh Method for the treatment of drug abuse with flibanserin
EP1888071A1 (en) * 2005-05-19 2008-02-20 Boehringer Ingelheim International GmbH Method for the treatment of drug-induced sexual dysfunction
US8227476B2 (en) 2005-08-03 2012-07-24 Sprout Pharmaceuticals, Inc. Use of flibanserin in the treatment of obesity
JP2009513604A (ja) 2005-10-29 2009-04-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 月経前障害及び他の女性の性的障害治療用のベンゾイミダゾロン誘導体
US20070123540A1 (en) * 2005-10-29 2007-05-31 Angelo Ceci Sexual desire enhancing medicaments comprising benzimidazolone derivatives
US20070105869A1 (en) * 2005-11-08 2007-05-10 Stephane Pollentier Use of flibanserin for the treatment of pre-menopausal sexual desire disorders
WO2007128802A2 (en) * 2006-05-09 2007-11-15 Boehringer Ingelheim International Gmbh Use of flibanserin for the treatment of post-menopausal sexual desire disorders
WO2008000760A1 (en) 2006-06-30 2008-01-03 Boehringer Ingelheim International Gmbh Flibanserin for the treatment of urinary incontinence and related diseases
US20090318469A1 (en) * 2006-07-14 2009-12-24 Boehringer Ingelheim International Gmbh Use of Flibanserin for the Treatment of Sexual Disorders in Females
KR20090042967A (ko) 2006-08-14 2009-05-04 베링거 인겔하임 인터내셔날 게엠베하 플리반세린 제형 및 이의 제조방법
CL2007002214A1 (es) 2006-08-14 2008-03-07 Boehringer Ingelheim Int Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp
AR062321A1 (es) 2006-08-25 2008-10-29 Boehringer Ingelheim Int Sistema de liberacion controlada y metodo para fabricarlo
HUE031039T2 (en) * 2007-03-29 2017-06-28 Joint-Stock Company Obninsk Chemical Pharmaceutical Company An antihistamine and an anti-allergenic agent and a method for its preparation
PE20091188A1 (es) 2007-09-12 2009-08-31 Boehringer Ingelheim Int Compuesto 1-[2-(4-(3-trifluorometil-fenil)piperazin-1-il)etil]-2,3-dihidro-1h-benzimidazol-2-ona (flibanserina), sus sales de adicion y composiciones farmaceuticas que los contienen
CA2686480A1 (en) 2008-12-15 2010-06-15 Boehringer Ingelheim International Gmbh New salts

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE637271A (es) * 1963-04-04 1900-01-01
DE1595923A1 (de) * 1965-02-20 1969-11-27 Merck Ag E 1-Aralkyl-4-(thiazolyl-2)-piperazine und Verfahren zu ihrer Herstellung
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
JPS5246935B1 (es) * 1971-04-06 1977-11-29
BE787059A (fr) * 1971-08-03 1973-02-01 Wander Ag Dr A Nouveaux derives du thiazole, leur preparation et leur application comme medicaments
CH583232A5 (es) * 1973-02-02 1976-12-31 Wander Ag Dr A
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method
US4423049A (en) * 1981-12-28 1983-12-27 Mead Johnson & Company 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines
DE3321969A1 (de) * 1983-06-18 1984-12-20 Troponwerke GmbH & Co KG, 5000 Köln 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
HUT43600A (en) * 1985-06-22 1987-11-30 Sandoz Ag Process for production of new thiazole derivatives and medical compound containing those

Also Published As

Publication number Publication date
LU86487A1 (fr) 1987-01-13
FI862644A (fi) 1986-12-23
IT8648157A0 (it) 1986-06-20
GB2177395A (en) 1987-01-21
FR2587342A1 (fr) 1987-03-20
SE8602723L (sv) 1986-12-23
IL79178A0 (en) 1986-09-30
PH23389A (en) 1989-07-26
GR861601B (en) 1986-10-20
ES556363A0 (es) 1988-04-01
ES557723A0 (es) 1988-03-16
DK292986D0 (da) 1986-06-20
AU5894086A (en) 1986-12-24
NL8601494A (nl) 1987-01-16
CH668426A5 (de) 1988-12-30
GB8614974D0 (en) 1986-07-23
SE8602723D0 (sv) 1986-06-18
BE904945A (fr) 1986-12-18
GB2177395B (en) 1989-04-26
HUT43600A (en) 1987-11-30
FI862644A0 (fi) 1986-06-19
IT1203806B (it) 1989-02-23
US4737500A (en) 1988-04-12
DK292986A (da) 1986-12-23
US4892879A (en) 1990-01-09
ES8802045A1 (es) 1988-03-16

Similar Documents

Publication Publication Date Title
ES8802154A1 (es) Procedimiento para la produccion de tiazoles.,
MY114889A (en) 1-phenyl-3-dimethylamino-propane derivatives having pharmacological activity
DE3671839D1 (de) Direkttablettierhilfsmittel.
FI864403A0 (fi) Ban- eller slangformig foerpackningsfolie, i synnerhet med spaerrskikt foersett korvskal.
MY103210A (en) Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds.
DE3273628D1 (en) Phosphonamidate compounds
ES8606339A1 (es) Procedimiento para la produccion de indolofenantridinas
GR850831B (es)
FI860226A (fi) Spiralelementband med skyddade kanter.
IL76345A (en) Proline derivatives and antihypertensive and anti-glaucoma pharmaceutical preparations containing the same
CA1265131C (en) ERYTHROMYCYLAMINE DERIVATIVES
AU580890B2 (en) P-acylaminobenzamides
MY102059A (en) Naphthoxazines
MY102026A (en) Antiasthmatic.
IT8520089A0 (it) Procedimento per la preparazionedi w-lattami, in particolare caprolattame.
IL107242A0 (en) Derivatives of benzeneborinic acid, preparation thereof and use thereof as synthetic intermediates
FI860225A0 (fi) Banformningsvira med foerstaerkta kanter.
AU5295486A (en) Pyrazolo 1,5-a-pyridin-3-yl or benzimidazol-2-yl derivatives
AU587293B2 (en) 5-heterocyclic-2,4-dialkyl-3H-1,2,4-triazole-3-thiones and their use as antidepressants
IT8521041A0 (it) Decapeptidi ad azione ipotensiva eprocedimento per la loro preparazione.
IT8622335A0 (it) Pirrolidin-2,5-dioni e loro impiego.
DE3686113D1 (de) Lymphokin, dessen herstellung und verwendungen.
AU587645B2 (en) 5-naphthyl-2,4-dialkyl-3H-1,2,4-triazole-3-thiones and their use as antidepressants
AU5672786A (en) Two-piece steel rail
SU1132513A1 (ru) 2-метиламино-4-оксо-3,6,6-триметил-5,6-дигидро-8н-пирано[4′,3′ : 4,5]тиено[2,3-d]пиримидин или его соли, обладающие противосудорожной активностью